← Every company

TuHURA Biosciences Inc SEC Filings

What TuHURA Biosciences Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.

HURA overview →
Filings on file
182
since Oct 7, 2016
Warning signs
18
latest Jan 30, 2026
Last results
Aug 14, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834

Newest first

Each label is a form type or an 8-K item as filed; each row links to the filing.

FiledWhat it reportsDocument
Sep 17, 2026
Executive or director change
8-K/A
Read ↗
Sep 16, 2026
Executive or director change
8-K
Read ↗
Apr 8, 2026
Executive or director change
8-K
Read ↗
May 7, 2025
Executive or director change
8-K/A
Read ↗
May 7, 2025
Executive or director changeMaterial agreement
8-K
Read ↗
Mar 12, 2025
Executive or director change
8-K
Read ↗
Nov 15, 2024
Executive or director change
8-K
Read ↗
Oct 21, 2024
Executive or director changeResults announcedAcquisition or sale completedChange in controlMaterial agreement
8-K
Read ↗
Apr 3, 2024
Executive or director changeMaterial agreement
8-K
Read ↗
Nov 21, 2023
Executive or director change
8-K
Read ↗
Jun 2, 2023
Executive or director change
8-K
Read ↗
May 24, 2022
Executive or director change
8-K
Read ↗
Feb 8, 2022
Executive or director change
8-K
Read ↗
Nov 12, 2021
Executive or director change
8-K
Read ↗
Oct 29, 2021
Executive or director change
8-K
Read ↗
May 3, 2021
Executive or director change
8-K
Read ↗
Aug 21, 2020
Delisting notice or listing transferExecutive or director changeAcquisition or sale completedMaterial agreementUnregistered share sale
8-K
Read ↗
Sep 9, 2019
Executive or director change
8-K
Read ↗
Apr 30, 2019
Executive or director change
8-K
Read ↗
Jun 25, 2018
Executive or director change
8-K
Read ↗
Jun 7, 2018
Executive or director change
8-K
Read ↗
May 22, 2018
Executive or director change
8-K
Read ↗
Dec 22, 2017
Executive or director change
8-K
Read ↗
Nov 8, 2017
Executive or director change
8-K
Read ↗
Jul 12, 2017
Executive or director change
8-K
Read ↗

Source: TuHURA Biosciences Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.

More on HURA

Related datasets